Roopa Industries

Hyderabad, India Founded: 2000 • Age: 26 yrs Listed
Nutraceuticals, bulk drugs, and chemicals are manufactured in Hyderabad.

About Roopa Industries

Roopa Industries is a publicly listed company based in Hyderabad (India) founded in 2000. Nutraceuticals, bulk drugs, and chemicals are manufactured in Hyderabad. The company has 30 employees. Its Indian entity Roopa Industries Limited reported revenue of β‚Ή128 Cr. Its focus areas include Diversified Pharmaceuticals.

Company details

Roopa Industries was established in 2000 in Hyderabad, India, within the pharmaceuticals and chemicals sector. Manufacturing operations focus on nutraceuticals such as glucosamine, bulk drugs including esomeprazole magnesium trihydrate and tamsulosin, and chemicals like triphenyl phosphine and bromine derivatives. These products support applications in antibiotics, agrochemicals, dyes, and medical intermediates, with activities centered in the Indian market.

  • Headquarters Hyderabad, India
  • Employees 30
  • Stage Public
  • Sectors
    Healthcare
  • Website roopaindustries.com
  • Social LinkedIn
  • Legal Name Roopa Industries Limited
Key Metrics
  • Market Cap
    ₹33.59 Cr

    ROOPAIND · BSE

  • Share Price
    ₹42.25

    -1.05% today

  • Revenue
    ₹128 Cr

    FY 2025-26 · +5.6% YoY

  • EBITDA
    ₹4.06 Cr

    Margin 3.2%

  • Net Profit
    ₹4.17 Cr

    FY 2025-26 · +112.8% YoY

  • P/E (TTM)
    8.0x

    P/B 1.8x

  • ROE
    23.8%

    ROCE 14.9%

  • Debt / Equity
    1.83

    Interest cover 98.8x

  • Employee Count
    30

Board of directors of Roopa Industries Limited (Roopa Industries)

Roopa Industries Limited is the primary company behind Roopa Industries. The board of Roopa Industries Limited currently have 5 directors; the longest-serving is Joginatha Vaduguri Sarma, appointed in 1999. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Joginatha Vaduguri Sarma
DIN 00165204
Whole-time director01 Oct 199927 yrs 1 moRoopa Industries Limited
Tumbalam Gooty Raghavendra
DIN 00186546
Managing Director01 Oct 201511 yrs 1 moRoopa Industries Limited
Karunasree Samudrala
DIN 06960974
Director26 Aug 20179 yrs 2 moRoopa Industries Limited
Muttaraju Venu Manohar
DIN 11272558
Director01 Oct 20251 yr 1 moRoopa Industries Limited
Gantla Venkat Reddy
DIN 11276913
Director01 Oct 20251 yr 1 moRoopa Industries Limited

IPO & Listings of Roopa Industries

Roopa Industries is a publicly listed company on the BSE with ticker symbol ROOPAIND in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date17 Aug 1995
  • Listed onBSE: 530991
  • Listed entityRoopa Industries Limited
  • Exchange sectorHealth technology
  • ISININE443C01010
  • Share price₹47.90 (+5.62% on the day) · 2026-10-14
  • Market capitalisation₹35.7 Cr
  • Price to earnings294.0
  • EPS (diluted, trailing year)₹0.16
  • Volume (last session)51

Financials of Roopa Industries

Exchange-reported figures of Roopa Industries Limited, the listed company behind Roopa Industries (BSE: ROOPAIND).

Financial Highlights

FY 2025-26 Β· Standalone
Revenue
₹128 Cr
+5.6% YoY
EBITDA
₹4.06 Cr
-1.5% YoY
Profit After Tax
₹4.17 Cr
+112.8% YoY
Net Worth
₹17.60 Cr
+0.6% YoY
Total Assets
₹49.30 Cr
-3.9% YoY
Total Debt
₹31.02 Cr
-6.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue12812170.4376.1751.2128.6127.65
Revenue growth+5.6%+71.4%-7.5%+48.7%+79.0%+3.5%-
EBITDA4.064.124.453.903.442.731.84
EBITDA margin+3.2%+3.4%+6.3%+5.1%+6.7%+9.5%+6.7%
Profit before tax0.172.732.191.821.360.940.81
Net profit4.171.961.461.371.010.720.38
Net profit margin+3.3%+1.6%+2.1%+1.8%+2.0%+2.5%+1.4%
EPS (β‚Ή)0.112.591.931.721.290.910.47
Balance sheet
Total assets49.3051.3041.7033.2724.9925.4324.73
Net worth17.6017.5015.4813.9512.5911.5710.80
Total debt31.0233.2625.7518.8711.9713.4613.51
Cash & bank1.544.624.152.732.011.000.73
Net working capital41.3142.9426.5419.7115.1315.5514.76
Cash flow
Cash from operations4.68(6.59)2.01(0.37)2.34(0.52)2.44
Cash from investing(0.49)2.181.11(0.99)3.651.340.70
Cash from financing(7.50)4.82(2.09)1.81(5.01)(0.58)(3.06)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue34.3033.3230.1433.5428.7435.0729.8330.73
Revenue growth (YoY)+19.4%-5.0%+1.0%+9.1%+12.2%+1.6%--
Other income0.000.020.110.000.000.021.140.92
Total expenses32.6331.8031.1631.5127.1133.6729.3929.76
EBITDA1.671.52(1.02)2.031.631.400.440.97
EBITDA margin+4.9%+4.6%-3.4%+6.1%+5.7%+4.0%+1.5%+3.2%
Depreciation0.190.190.210.190.190.200.190.26
Interest1.020.930.740.790.830.860.660.67
Profit before tax0.460.42(1.86)1.050.610.360.730.96
Tax0.100.10(0.43)0.280.150.090.320.20

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 21 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue34.3033.3230.1433.5428.7435.0729.8330.73
Revenue growth (YoY)+19.4%-5.0%+1.0%+9.1%+12.2%+1.6%--
Other income0.000.020.110.000.000.021.140.92
Total expenses32.6331.8031.1631.5127.1133.6729.3929.76
EBITDA1.671.52(1.02)2.031.631.400.440.97
EBITDA margin+4.9%+4.6%-3.4%+6.1%+5.7%+4.0%+1.5%+3.2%
Depreciation0.190.190.210.190.190.200.190.26
Interest1.020.930.740.790.830.860.660.67
Profit before tax0.460.42(1.86)1.050.610.360.730.96
Tax0.100.10(0.43)0.280.150.090.320.20
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue12812170.4376.1751.2128.6127.65
Revenue growth+5.6%+71.4%-7.5%+48.7%+79.0%+3.5%-
Other income0.132.301.130.650.060.081.09
Total expenses12311765.9872.2747.7725.8825.81
Employee cost2.932.833.473.242.213.772.36
EBITDA4.064.124.453.903.442.731.84
EBITDA margin+3.2%+3.4%+6.3%+5.1%+6.7%+9.5%+6.7%
Depreciation0.800.850.870.890.930.810.76
Interest3.222.842.521.841.211.061.36
Profit before tax0.172.732.191.821.360.940.81
Tax0.090.690.650.450.350.220.43
Net profit4.171.961.461.371.010.720.38
Net profit margin+3.3%+1.6%+2.1%+1.8%+2.0%+2.5%+1.4%
EPS (β‚Ή)0.112.591.931.721.290.910.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital7.877.877.877.877.877.877.87
Reserves & surplus9.739.637.616.084.723.702.93
Shareholders' funds (net worth)17.6017.5015.4813.9512.5911.5710.80
Secured loans29.5528.0222.5917.756.048.147.52
Unsecured loans1.475.243.161.125.935.325.99
Total debt31.0233.2625.7518.8711.9713.4613.51
Total liabilities49.3051.3041.7033.2724.9925.4324.73
Assets
Gross block18.8617.5818.1919.4518.3218.0617.42
Net block8.417.938.739.979.6910.3610.53
Capital work in progress0.000.880.880.880.690.100.00
Investments0.010.020.020.010.010.010.01
Inventories30.8436.1525.1618.3815.3419.4612.35
Sundry debtors21.9213.008.357.0815.6811.5011.90
Cash & bank balances1.544.624.152.732.011.000.73
Loans & advances8.8913.5210.9813.915.263.562.33
Total current assets63.1967.2948.6442.1038.2935.5227.31
Total current liabilities21.8824.3522.1022.3923.1619.9712.55
Net working capital41.3142.9426.5419.7115.1315.5514.76
Total assets49.3051.3041.7033.2724.9925.4324.73
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.382.981.951.490.500.260.17
Net cash from operating activities4.68(6.59)2.01(0.37)2.34(0.52)2.44
Net cash from investing activities(0.49)2.181.11(0.99)3.651.340.70
Net cash from financing activities(7.50)4.82(2.09)1.81(5.01)(0.58)(3.06)
Net change in cash(3.31)0.401.030.450.990.250.08
Closing cash1.544.624.152.732.011.000.73
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+5.6%+71.4%-7.5%+48.7%+79.0%+3.5%-
EBITDA growth-1.5%-7.4%+14.1%+13.4%+26.0%+48.4%-
PBT growth-93.8%+24.7%+20.3%+33.8%+44.7%+16.1%+1.3%
Net income growth+112.8%+34.3%+6.6%+35.6%+40.3%+89.5%-
Revenue CAGR (3Y)+18.7%+33.1%+35.0%+40.2%+19.3%+14.7%-2.7%
EBITDA CAGR (3Y)+1.4%+6.2%+17.7%+28.5%+11.1%--6.4%
Profitability & leverage
Net income margin+0.1%+1.7%+2.2%+1.8%+2.0%+2.5%+1.4%
Return on capital employed+14.9%+12.0%+12.5%+12.5%+10.2%+8.0%+8.5%
Return on net worth+23.8%+12.3%+10.3%+10.2%+8.4%+6.4%+3.5%
Debt / equity1.831.791.521.161.051.211.35
Long-term debt / equity0.270.370.240.160.370.530.63
Interest cover98.7786.8570.3961.1348.2155.21125.93
Efficiency & per share
Fixed asset turnover7.006.753.744.032.821.611.85
Inventory turnover3.813.943.244.522.941.802.40
Debtors turnover7.3011.319.136.693.772.452.41
EPS (β‚Ή)0.112.591.931.721.290.910.47
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)22.3722.2419.6717.7316.0014.7013.73
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Roopa Industries

Premium access

Complete news archive for Roopa Industries

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roopa Industries

Roopa Industries was founded in 2000.

Roopa Industries is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Roopa Industries has 30 employees.

The primary company behind Roopa Industries, Roopa Industries Limited, reported revenue of β‚Ή128 Cr for FY 2026, up 6% year on year.

Roopa Industries was established in 2000 in Hyderabad, India, within the pharmaceuticals and chemicals sector. Manufacturing operations focus on nutraceuticals such as glucosamine, bulk drugs including esomeprazole magnesium trihydrate and tamsulosin, and chemicals like triphenyl phosphine and bromine derivatives. These products support applications in antibiotics, agrochemicals, dyes, and medical intermediates, with activities centered in the Indian market.

Yes, Roopa Industries is publicly traded on BSE under the ticker symbol ROOPAIND.

Roopa Industries operates through Roopa Industries Limited.

The legal entities of Roopa Industries currently have 7 directors, including Karunasree Samudrala, Joginatha Vaduguri Sarma, Tumbalam Gooty Raghavendra and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available